Search Results

You are looking at 41 - 50 of 55 items for :

Clear All
Free access

Jan Wilde, Maria Erdmann, Michael Mertens, Gabriele Eiselt and Martin Schmidt

proliferator-activated receptor-γ (PPARG; Rubin et al . 2000 , 2002 ). In adipose tissue in the vicinity of many breast tumors, promoter II is dominant, whereas it is not normally used in adipose tissue. This promoter is induced by cAMP-elevating agonists, e

Free access

Shaoqian Zhao, Wen Liu, Jiqiu Wang, Juan Shi, Yingkai Sun, Weiqing Wang, Guang Ning, Ruixin Liu and Jie Hong

( Fig. 2B ). The most important function of ACC is to provide the malonyl-CoA substrate for the biosynthesis of fatty acids ( Tong 2005 ). However, we did not observe similar changes in adipose tissue ( Fig. 2C ). Gene expression of C/EBPA and PPARG

Free access

Margarita M Ivanova, Brandie N Radde, Jieun Son, Fabiola F Mehta, Sang-Hyuk Chung and Carolyn M Klinge

). In conclusion, Ppargc1a expression was not regulated by E 2 or 4-OHT in MG and decreased in uterus ( Fig. 6A ), consistent with the reports that E 2 repressed PGC-1α in mouse uterus ( Macari et al . 2010 ), GeoProfile GDS1058 showed Pparg1c in

Free access

Gilberto Paz-Filho, Claudio Alberto Mastronardi, Brian J Parker, Ainy Khan, Antonio Inserra, Klaus I Matthaei, Monika Ehrhart-Bornstein, Stefan Bornstein, Ma-Li Wong and Julio Licinio

metabolism Gstm3 −3.8226 0.0005 Gpx6 5.0516 0.003 Gpx4 −1.4507 0.0415 Gsta1 −2.5128 0.0225 Gstp2 3.8300 0.0089 PPAR signaling pathway Pparg −1.6606 0.0018 Cd36 −1.9234 0.0005 Fabp5 3.2580 0.0024 Reactome biological  oxidation pathway Cyp7b1 11.0988 0.0012 Cyp

Free access

Marcel J M Schaaf

activity . Environmental Science and Technology 36 4410 – 4415 . ( doi:10.1021/es010323a ) Li N Kelsh RN Croucher P Roehl HH 2010 Regulation of neural crest cell fate by the retinoic acid and Pparg signalling pathways

Free access

Xiaoqi Lin, Sydney D Finkelstein, Bing Zhu and Jan F Silverman

. 2004 ), LOHs of 1q, 4p, 7q, 9p, 9q, and 16q ( Kitamura et al . 2000 ), t(2;3) (q13;q25) ( PAX8-PPARG ) (thyroid transcription factor-peroxisome proliferator-activated receptor) ( Castro et al . 2005 ), Ras mutation ( Zhu et al . 2003 ), phosphatase

Free access

Jonathan Pham, Kanaga Arul Nambi Rajan, Ping Li and Mana M Parast

Comparative Physiology 291 R1085 – R1093 . ( https://doi.org/10.1152/ajpregu.00794.2005 ) 10.1152/ajpregu.00794.2005) Parast MM Yu H Ciric A Salata MW Davis V Milstone DS 2009 PPARg regulates trophoblast proliferation and promotes

Open access

Jian-Hua Chen, Maria Segni, Felicity Payne, Isabel Huang-Doran, Alison Sleigh, Claire Adams, UK10K Consortium, David B Savage, Stephen O'Rahilly, Robert K Semple and Inês Barroso

resistance ( INSR , PIK3R1 , AKT2 , TBC1D4 , LMNA , PPARG , BSCL2 , AGPAT2 , PTRF , CAV1 , PCNT , NSMCE2 , ALMS1 , WRN , and BLM ). After removing any variants found in the listed genes with a non-reference allele frequency >1% in any of the

Free access

Jiayu Jin, Xinhong Wang, Xiuling Zhi and Dan Meng

Silambarasan et al. (2016) miR-29b-3p Up HUVEC MCL1, BCL2, VEGFA, PTEN Angiogenesis, apoptosis Silambarasan et al. (2016) miR-130b-3p Up HUVEC PTEN, STAT3, PPARG Pathological angiogenesis, tumor growth, endothelial activation

Free access

Carla Caruso, Lila Carniglia, Daniela Durand, Teresa N Scimonelli and Mercedes Lasaga

in glial cells. NDP-MSH increases PPARγ (PPARG) protein levels whereas it decreases PPARβ (PPARD) protein levels in astrocytes ( Carniglia et al . 2013 ), an effect that has also been described for LPS ( Jana & Pahan 2012 ). In addition, anti